Tuberculosis Screening Options Pros and Cons

Podcast

Sponsored Content

Listen to our Podcast on A Personal Perspective on TB Screening

Listen to our Podcast on Making Sense of TB Testing Guidelines

Listen to our Podcast on Tuberculosis Screening 101: A Primer

Download our Supplement on Importance of Screening for Tuberculosis Infection in the Ob/Gyn Community

Amita Gupta, MD, MHS, discusses the efficacy and limitations of screening options, including the protein purified derivative (PPD) test, and interferon gamma release assays using either a chemiluminescence automated platform or an enzyme-linked immunospot assay.

Presented by: Amita Gupta, MD MHS

Deputy Director of Center for Clinical Global Health Education, Professor of Infectious Diseases

School of Medicine and Bloomberg School of Public Health

Dr. Amita Gupta is Deputy Director of the Johns Hopkins (JH) Center for Clinical Global Health Education (CCGHE), and Professor of Infectious Diseases at the JH School of Medicine, with a joint appointment in International Health at the JH Bloomberg School of Public Health.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
Related Content
© 2024 MJH Life Sciences

All rights reserved.